| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.089 | 0.1 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.15 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.32 | 0.1 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |